397 related articles for article (PubMed ID: 30916978)
1. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
[TBL] [Abstract][Full Text] [Related]
2. In vitro porcine blood-brain barrier model for permeability studies: pCEL-X software pKa(FLUX) method for aqueous boundary layer correction and detailed data analysis.
Yusof SR; Avdeef A; Abbott NJ
Eur J Pharm Sci; 2014 Dec; 65():98-111. PubMed ID: 25239510
[TBL] [Abstract][Full Text] [Related]
3. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
[TBL] [Abstract][Full Text] [Related]
4. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
[TBL] [Abstract][Full Text] [Related]
5. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
6. Primary porcine brain microvascular endothelial cells: biochemical and functional characterisation as a model for drug transport and targeting.
Smith M; Omidi Y; Gumbleton M
J Drug Target; 2007 May; 15(4):253-68. PubMed ID: 17487694
[TBL] [Abstract][Full Text] [Related]
7. Culture-induced changes in mRNA expression levels of efflux and SLC-transporters in brain endothelial cells.
Goldeman C; Ozgür B; Brodin B
Fluids Barriers CNS; 2020 Apr; 17(1):32. PubMed ID: 32321539
[TBL] [Abstract][Full Text] [Related]
8. Murine in vitro model of the blood-brain barrier for evaluating drug transport.
Shayan G; Choi YS; Shusta EV; Shuler ML; Lee KH
Eur J Pharm Sci; 2011 Jan; 42(1-2):148-55. PubMed ID: 21078386
[TBL] [Abstract][Full Text] [Related]
9. Permeability of endothelial and astrocyte cocultures: in vitro blood-brain barrier models for drug delivery studies.
Li G; Simon MJ; Cancel LM; Shi ZD; Ji X; Tarbell JM; Morrison B; Fu BM
Ann Biomed Eng; 2010 Aug; 38(8):2499-511. PubMed ID: 20361260
[TBL] [Abstract][Full Text] [Related]
10. A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes.
Thomsen LB; Burkhart A; Moos T
PLoS One; 2015; 10(8):e0134765. PubMed ID: 26241648
[TBL] [Abstract][Full Text] [Related]
11. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
[TBL] [Abstract][Full Text] [Related]
12. An Improved In Vitro Porcine Blood-Brain Barrier Model for Permeability Screening and Functional Studies.
Patabendige A
Methods Mol Biol; 2022; 2492():131-142. PubMed ID: 35733042
[TBL] [Abstract][Full Text] [Related]
13. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
[TBL] [Abstract][Full Text] [Related]
14. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
[TBL] [Abstract][Full Text] [Related]
15. The blood-brain barrier studied in vitro across species.
Thomsen MS; Humle N; Hede E; Moos T; Burkhart A; Thomsen LB
PLoS One; 2021; 16(3):e0236770. PubMed ID: 33711041
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance.
Patabendige A; Skinner RA; Abbott NJ
Brain Res; 2013 Jul; 1521():1-15. PubMed ID: 22789905
[TBL] [Abstract][Full Text] [Related]
17. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
Silwedel C; Förster C
J Neuroimmunol; 2006 Oct; 179(1-2):37-45. PubMed ID: 16884785
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood-brain barrier.
Kusch-Poddar M; Drewe J; Fux I; Gutmann H
Brain Res; 2005 Dec; 1064(1-2):21-31. PubMed ID: 16289483
[TBL] [Abstract][Full Text] [Related]
19. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
[TBL] [Abstract][Full Text] [Related]
20. In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery.
Lacombe O; Videau O; Chevillon D; Guyot AC; Contreras C; Blondel S; Nicolas L; Ghettas A; Bénech H; Thevenot E; Pruvost A; Bolze S; Krzaczkowski L; Prévost C; Mabondzo A
Mol Pharm; 2011 Jun; 8(3):651-63. PubMed ID: 21438632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
